Securing cosmeceutical sales through exclusive distribution and E-commerce
CureNology
Product
Product
Le Laffé
the Future of Holistic Skincare
Discovering a way to improve skin aging caused by premature aging through persistent research and making it possible to return to healthy and beautiful skin.






Category: Cosmeceutical product
Status: Launched (2024)


Reverse Ager CNF-1 &
CN Skin Regeneration
Reverse aging injection for skin
Full skin (Dermis + Epidermis) Regeneration
Lifting & reverse aging
Category: Medical Devices (Injection)
Status: In development (Launch in 2025)




Bio-Med products
Regeneration solution for medical use
Category: Medical Devices
Status: In development
Gum
Regeneration
Status
In vitro study
Proof of the concept
Spinal Disc
Regeneration
Status
In vitro study
Proof of the concept
Disc regeneration patch
Multi-hair Cloning/
Regeneration
Status
In vitro study
Proof of the concept
Cartilage
Regeneration
Status:
In vitro study
Proof of the concept
Focusing on knee & joints


Product Plan & Milestones
2024
Le Laffé
FDA, CPNP listed
Category
Cosmeceutical
Function
Wrinkle Relieve
Skin Tone-up
Faster skin turnover
Reduced inflammation


2023
Le Laffé skin Seoul Project development
Reverse Ager CNF-1 development
2025
Reverse Ager CNF-1 & CN Skin Regeneration
Category
Medical Devices
Function
Lifting
Reverse Aging
Full skin Regeneration


2026
Cartil-regen
& Disc Regen
Category
Medical Devices


2028
Hair Cloning
Category
Medical Devices
Milestone
Patented (PCT)
· Stem Cell Secretome
· Transdermal delivery system
· Micro-spear
Proprietary IP for ECM technology specialized for skin applications.
Manufacturing facility setup
E-commerce system open
Learn more about
CureNology highlight


Learn more about
CureNology Technology
Be our partner
Contact us




CureNology
Pioneering Regenerative Biomedical product with ECM Technology
Health
Vitality
CureNology inc.
#1316, Build’g 101, 223 Sinheung-ro. Wonmi-gu, Bucheon, Gyeonggi-do, Rep. of Korea, 14539
Email info@curenology.com
CureNology © 2024. All rights reserved.